Alcohol, Other Drugs, and Health: Current Evidence

Search
Menu Search
  • Home
  • Current Issue
  • Issues
  • Free Subscriptions
  • Podcast
  • Slide Presentations
  • Ethical Conduct of AOD Research
  • Curricula and Links
  • About the Newsletter
  • Contact Us
Search

September-October 2025

Interventions and Assessments

  • Characteristics of Medetomidine Withdrawal Among People With Concurrent Fentanyl Use

Health Outcomes

  • Among Individuals Receiving Buprenorphine, Prescribed Stimulant Receipt Does Not Increase the Risk of Opioid-related Overdose
  • Among People Admitted for an Overdose, Opioid Agonist Treatment is Associated With a Decreased Risk of Future Overdose
  • Rising Opioid-related Overdose Mortality Rates in the American Indian and Alaska Native Communities, 1999–2021
  • A Canary in the Coal Mine: How Medicaid Cuts Could Impact Millions of Americans With Opioid Use Disorder

Prescription Drugs and Pain

  • Decreasing Opioid Dose Trajectory in Patients Prescribed Opioids Long Term Associated with Adverse Clinical Outcomes
  • Among Individuals With Opioid Use Disorder, Initiation of Extended-release Naltrexone Did Not Increase Pain Intensity

Download PDF of newsletter

Grayken Center for Addiction at Boston Medical Center

Bringing you the latest clinically relevant research on substance use and health.

Boston University
Boston University Medical Center
Grayken Center for Addiction